Xtant Medical Holdings, Inc. - Common Stock (XTNT)
CUSIP: 98420P308
Q2 2023 13F Holders as of 30 Jun 2023
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 140,036,400
- Total 13F shares
- 81,765,290
- Share change
- -88,824
- Total reported value
- $76,033,381
- Price per share
- $0.93
- Number of holders
- 19
- Value change
- -$53,515
- Number of buys
- 5
- Number of sells
- 5
Quarterly Holders Quick Answers
What is CUSIP 98420P308?
CUSIP 98420P308 identifies XTNT - Xtant Medical Holdings, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 98420P308:
Top shareholders of XTNT - Xtant Medical Holdings, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
|
Company |
52%
|
73,114,592
|
$46,610,552 | — | 31 Mar 2023 | |
| Matthew Rizzo |
3/4/5
|
Director, 10%+ Owner |
—
class O/S missing
|
17,325,033
|
$10,552,677 | — | 15 Aug 2022 | |
| Michael Eggenberg |
3/4/5
|
Director, 10%+ Owner |
—
class O/S missing
|
17,325,033
|
$10,552,677 | — | 15 Aug 2022 | |
| Altium Capital Management LLC |
13F
|
Company |
4.4%
|
6,227,559
|
$3,970,069 | — | 31 Mar 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.91%
|
1,279,052
|
$815,396 | — | 31 Mar 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.43%
|
602,810
|
$384,000 | — | 31 Mar 2023 | |
| Jeffrey J. Peters |
3/4/5
|
Director |
—
class O/S missing
|
448,546
|
$273,209 | — | 15 Aug 2022 | |
| Greg Jensen |
3/4/5
|
Vice President, Finance & CFO |
—
mixed-class rows
|
477,639
mixed-class rows
|
$173,795 | — | 15 Aug 2021 | |
| Crescent Grove Advisors, LLC |
13F
|
Company |
0.19%
|
262,024
|
$167,040 | — | 31 Mar 2023 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.08%
|
114,500
|
$72,994 | — | 31 Mar 2023 | |
| Virtu Financial LLC |
13F
|
Company |
0.05%
|
75,240
|
$48,000 | — | 31 Mar 2023 | |
| Midwest Professional Planners, LTD. |
13F
|
Company |
0.03%
|
40,744
|
$25,974 | — | 31 Mar 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.02%
|
23,666
|
$15,087 | — | 31 Mar 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.02%
|
23,593
|
$15,040 | — | 31 Mar 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.02%
|
22,503
|
$14,346 | — | 31 Mar 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.02%
|
21,061
|
$13,426 | — | 31 Mar 2023 | |
| OneDigital Investment Advisors LLC |
13F
|
Company |
0.01%
|
17,255
|
$11,000 | — | 31 Mar 2023 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0.01%
|
16,120
|
$10,277 | — | 31 Mar 2023 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
7,063
|
$4,499 | — | 31 Mar 2023 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
5,279
|
$3,000 | — | 31 Mar 2023 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
316
|
$202 | — | 31 Mar 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
311
|
$198 | — | 31 Mar 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
195
|
$124 | — | 31 Mar 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0%
|
143
|
$91 | — | 31 Mar 2023 | |
| FMR LLC |
13F
|
Company |
0%
|
88
|
$56 | — | 31 Mar 2023 |
Institutional Holders of Xtant Medical Holdings, Inc. - Common Stock (XTNT) as of Q2 2023
As of 30 Jun 2023,
Xtant Medical Holdings, Inc. - Common Stock (XTNT) was held by
19 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
81,765,290 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, Altium Capital Management LP, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, Crescent Grove Advisors, LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, Midwest Professional Planners, LTD., CITADEL ADVISORS LLC, TWO SIGMA SECURITIES, LLC, and STATE STREET CORP.
This page lists
19
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
21
Q2 2023 holders
19
Holder diff
-2
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.